HOPLITE CAPITAL MANAGEMENT, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+69,234
(1.9%)
New positions
11
Sold out positions
15
Turnover %
70.1%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SUNEDISON, INC. | 301,637 | NEW |
| CTXS | 141,725 | NEW |
| Endo International plc | 118,632 | NEW |
| NORTHSTAR RLTY FIN CORP | 116,633 | NEW |
| KEURIG GREEN MOUNT | 106,161 | NEW |
| MU | 101,712 | NEW |
| CX | 97,468 | NEW |
| SOLARWINDS INC COM | 87,633 | NEW |
| WALGREEN CO | 82,956 | 141.9% |
| PANDORA MEDIA INC | 64,377 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| MONSTER BEVERAGE CORP NE | -158,907 | -100.0% |
| DG | -119,247 | -100.0% |
| EQIX | -117,067 | -100.0% |
| TMO | -106,054 | -100.0% |
| NBIS | -102,234 | -100.0% |
| BUD | -101,276 | -100.0% |
| VOD | -100,241 | -100.0% |
| HLF | -79,117 | -100.0% |
| CRI | -77,097 | -100.0% |
| ENDO PHARMACEUTICALS HLDGS | -68,537 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
59,033
(1.6% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|